BIOCRYST PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of BCRX for the last quarter is 2.31 B MXN, and it's 15.04% higher compared to the previous quarter. The net income of Q3 24 is -276.50 M MXN.